Articles | Volume 6, issue 4
https://doi.org/10.5194/jbji-6-107-2021
© Author(s) 2021. This work is distributed under the Creative Commons Attribution 4.0 License.
Case report
| 
22 Feb 2021
Case report |
| 22 Feb 2021
| 22 Feb 2021
Mycobacterium bovis BCG osteoarticular infection complicating immune therapy for bladder cancer: a case report
Cited articles
Hlavsa, M. C., Moonan, P. K., Cowan, L. S., Navin, T. R., Kammerer, J. S.,
Morlock, G. P., Crawford, J. T., and LoBue, P. A.: Human Tuberculosis due to
Mycobacterium bovis in the United States, 1995–2005, Clin. Infect. Dis., 47, 168–175, https://doi.org/10.1086/589240, 2008.
Hogan, J. I., Hurtado, R. M., and Nelson, S. B.: Mycobacterial
Musculoskeletal Infections, Infect. Dis. Clin. North Am., 31, 369–382,
https://doi.org/10.1016/j.idc.2017.01.007, 2017.
Lamm, D. L.: Efficacy and safety of bacille Calmette-Guérin
immunotherapy in superficial bladder cancer, Clin. Infect. Dis., 31, Suppl. 3,
S86–90, https://doi.org/10.1086/314064, 2000.
Liu, Y., Lu, J., Huang, Y., and Ma, L.: Clinical Spectrum of Complications
Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for
Bladder Cancer, J. Oncol., 2019, 6230409, https://doi.org/10.1155/2019/6230409, 2019.
Nguyen, M. H., Giordani, M. M., and Thompson III, G. R.: The double-edged
sword – prosthetic joint infection following BCG treatment for bladder
cancer: a case report, BMC Infect. Dis., 19, 331, https://doi.org/10.1186/s12879-019-3951-1,
2019.
